At the basal level, mice from both genotypes treated with TAM and without tumor inoculation showed no difference in 12 out of the 13 cytokines tested, with the exception being IL-27, which was increased by ~3-fold in Sftpc-KO mice. This evidence concerns the gene SFTPC and neoplasm.